Last reviewed 2026-05-24 · How we verify

Elemene plus first or third generation EGFR-TKIs

Tian Xie · FDA-approved active Small molecule ✓ Verified May 2026 Quality 2/100

Elemene plus first or third generation EGFR-TKIs is a Small molecule drug developed by Tian Xie. It is currently FDA-approved. Also known as: H10960114, H20010338.

Elemene is a small molecule that is being studied in combination with first or third generation EGFR-TKIs for the treatment of non-small-cell lung cancer, specifically in patients with EGFR-mutated advanced NSCLC. The combination of elemene and EGFR-TKIs is being investigated in a prospective study (NCT04401059) to evaluate its synergistic effect compared to EGFR-TKIs alone.

At a glance

Generic name	Elemene plus first or third generation EGFR-TKIs
Also known as	H10960114, H20010338
Sponsor	Tian Xie
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Elemene plus first or third generation EGFR-TKIs CI brief — competitive landscape report
Elemene plus first or third generation EGFR-TKIs updates RSS · CI watch RSS
Tian Xie portfolio CI

Frequently asked questions about Elemene plus first or third generation EGFR-TKIs

What is Elemene plus first or third generation EGFR-TKIs?

Elemene plus first or third generation EGFR-TKIs is a Small molecule drug developed by Tian Xie.

Who makes Elemene plus first or third generation EGFR-TKIs?

Elemene plus first or third generation EGFR-TKIs is developed and marketed by Tian Xie (see full Tian Xie pipeline at /company/tian-xie).

Is Elemene plus first or third generation EGFR-TKIs also known as anything else?

Elemene plus first or third generation EGFR-TKIs is also known as H10960114, H20010338.

What development phase is Elemene plus first or third generation EGFR-TKIs in?

Elemene plus first or third generation EGFR-TKIs is FDA-approved (marketed).

Manufacturer: Tian Xie — full pipeline
Also known as: H10960114, H20010338

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing